BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16932300)

  • 1. A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy.
    Szmuilowicz ED; Utiger RD
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):291-6; quiz 297. PubMed ID: 16932300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.
    Akinci B; Comlekci A; Tankurt E
    Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):142-5. PubMed ID: 18561096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.
    Takeuchi Y; Takahashi S; Miura D; Katagiri M; Nakashima N; Ohishi H; Shimazaki R; Tominaga Y
    J Bone Miner Metab; 2017 Nov; 35(6):616-622. PubMed ID: 27873072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
    Silverberg SJ; Rubin MR; Faiman C; Peacock M; Shoback DM; Smallridge RC; Schwanauer LE; Olson KA; Klassen P; Bilezikian JP
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3803-8. PubMed ID: 17666472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional parathyroid cystic adenoma: A rare cause of hypercalcemic crisis with primary hyperparathyroidism.
    Sumana BS; Sabaretnam M; Sarathi V; Savith A
    Indian J Pathol Microbiol; 2015; 58(4):487-90. PubMed ID: 26549073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoperoxidase confirmation of ultrasonically guided fine needle aspirates in patients with recurrent hyperparathyroidism.
    Sardi A; Bolton JS; Mitchell WT; Merritt CR
    Surg Gynecol Obstet; 1992 Dec; 175(6):563-8. PubMed ID: 1448738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel use of cinacalcet to distinguish primary hyperparathyroidism from hypercalcemia of malignancy in a patient with a low-normal parathyroid hormone concentration.
    Zwerling HK
    Endocr Pract; 2012; 18(1):101-2. PubMed ID: 22336445
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic fine-needle aspiration biopsy of an intrathyroidal parathyroid gland and subsequent eucalcemia in a patient with primary hyperparathyroidism.
    Ing SW; Pelliteri PK
    Endocr Pract; 2008; 14(1):80-6. PubMed ID: 18238745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid FNA and hormone assay.
    Derreberry T; Yaqub A
    W V Med J; 2009; 105(5):30-4. PubMed ID: 19806869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hyperparathyroidism. An alternative to the surgery].
    Díaz Guardiola P; Vega Piñero B; Alameda Hernando C; Pavón de Paz I; Iglesias Bolaños P; Guijarro de Armas G
    Endocrinol Nutr; 2009 Mar; 56(3):132-5. PubMed ID: 19627726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride.
    Sloand JA; Shelly MA
    Am J Kidney Dis; 2006 Nov; 48(5):832-7. PubMed ID: 17060004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience].
    Pelizzo MR; Piotto A; Bergamasco A; Rubello D; Casara D
    Minerva Endocrinol; 2001 Mar; 26(1):23-9. PubMed ID: 11323564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium hypercalcemia, hyperparathyroidism, and cinacalcet.
    Gregoor PS; de Jong GM
    Kidney Int; 2007 Mar; 71(5):470. PubMed ID: 17315015
    [No Abstract]   [Full Text] [Related]  

  • 15. Cinacalcet in the treatment of intractable hypercalcemia following two neck exploration surgeries for primary hyperparathyroidism.
    Padmanabhan H
    South Med J; 2010 Mar; 103(3):272-5. PubMed ID: 20134376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent.
    Collins MT; Skarulis MC; Bilezikian JP; Silverberg SJ; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1083-8. PubMed ID: 9543122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In the labyrinth of calcium metabolism].
    Magony S; Valkusz Z; Csajbók E; Sepp K; Gardi J; Szécsi M; Julesz J; Wittmann T
    Orv Hetil; 2013 Mar; 154(9):351-5. PubMed ID: 23434885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid carcinoma presenting as severe hypercalcaemia responding to steroids.
    Mathew SV; Ellis T; Jude EB
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37130631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of parathyroid levels and bone densitometry after cinacalcet treatment in severe primary hyperparathyroidism.
    Ogrin C
    Minerva Endocrinol; 2013 Sep; 38(3):337-8. PubMed ID: 24126554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.